Fundraising FoxRevamp Medical
Netanya, IL · 3 known investors
Find your way into Revamp Medical
Sign up to see every warm intro you have to Revamp Medical
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Revamp Medical team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Revamp Medical develops Doraya, a flow-reducing central venous catheter deployed in the infrarenal IVC to improve the efficacy of diuretic therapy in patients with acute heart failure. The device helps cardiologists temporarily manage venous hemodynamics, central venous pressure, and renal afterload to reduce hospital stays and readmissions.
Investors · 3
Accelmed Partnerslisted by Accelmed PartnersMiami
How we know: Accelmed Partners's portfolio page · prnewswire.com · Not right? Tell us
Arkin CapitalreportedHerzliya
How we know: prnewswire.com · Not right? Tell us
Also in the syndicate · 1
KCK Medtechlead
Funding
SEC filings, press & company announcementsSource: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Revamp Medical do?
- Revamp Medical develops Doraya, a flow-reducing central venous catheter deployed in the infrarenal IVC to improve the efficacy of diuretic therapy in patients with acute heart failure. The device helps cardiologists temporarily manage venous hemodynamics, central venous pressure, and renal afterload to reduce hospital stays and readmissions.
- Who are Revamp Medical's investors?
- Revamp Medical's investors include Accelmed Partners, Arkin Capital.
- Where is Revamp Medical headquartered?
- Revamp Medical is headquartered in Netanya, IL.